| Master transcription factors and mediator establish super-enhancers at key cell identity genes WA Whyte, DA Orlando, D Hnisz, BJ Abraham, CY Lin, MH Kagey, ... Cell 153 (2), 307-319, 2013 | 3768 | 2013 |
| Enhancer decommissioning by LSD1 during embryonic stem cell differentiation WA Whyte, S Bilodeau, DA Orlando, HA Hoke, GM Frampton, CT Foster, ... Nature 482 (7384), 221-225, 2012 | 631 | 2012 |
| Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation J Shi, WA Whyte, CJ Zepeda-Mendoza, JP Milazzo, C Shen, JS Roe, ... Genes & development 27 (24), 2648-2662, 2013 | 472 | 2013 |
| Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2 A Kanhere, K Viiri, CC Araújo, J Rasaiyaah, RD Bouwman, WA Whyte, ... Molecular cell 38 (5), 675-688, 2010 | 450 | 2010 |
| ZFHX4 interacts with the NuRD core member CHD4 and regulates the glioblastoma tumor-initiating cell state Y Chudnovsky, D Kim, S Zheng, WA Whyte, M Bansal, MA Bray, S Gopal, ... Cell reports 6 (2), 313-324, 2014 | 164 | 2014 |
| The polycomb group protein L3mbtl2 assembles an atypical PRC1-family complex that is essential in pluripotent stem cells and early development J Qin, WA Whyte, E Anderssen, E Apostolou, HH Chen, S Akbarian, ... Cell stem cell 11 (3), 319-332, 2012 | 150 | 2012 |
| Ronin/Hcf-1 binds to a hyperconserved enhancer element and regulates genes involved in the growth of embryonic stem cells M Dejosez, SS Levine, GM Frampton, WA Whyte, SA Stratton, MC Barton, ... Genes & development 24 (14), 1479-1484, 2010 | 133 | 2010 |
| Embryonic stem cell–based mapping of developmental transcriptional programs EO Mazzoni, S Mahony, M Iacovino, CA Morrison, G Mountoufaris, ... Nature methods 8 (12), 1056-1058, 2011 | 87 | 2011 |
| An adaptive algorithm for motion compensated color image coding S Kwatra, CM Lin, W Whyte IEEE transactions on communications 35 (7), 747-754, 1987 | 51 | 1987 |
| Super-enhancers and methods of use thereof RA Young, W Whyte, D Hnisz, J Loven, H Hoke, D Orlando, CY Lin, T Lee US Patent 9,181,580, 2015 | 8 | 2015 |
| Super-enhancers and methods of use thereof RA Young, W Whyte, D Hnisz, J Loven, H Hoke, D Orlando, CY Lin, T Lee US Patent App. 14/063,337, 2014 | 6 | 2014 |
| Author Correction: Enhancer decommissioning by LSD1 during embryonic stem cell differentiation WA Whyte, S Bilodeau, DA Orlando, HA Hoke, GM Frampton, CT Foster, ... Nature 562 (7728), E24-E24, 2018 | 4 | 2018 |
| Racial disparities in newly diagnosed hematological malignancies in the United States during the COVID-19 pandemic, January 2020 to March 2021 S Bhandari, J Chawla, P Jain, A Kaushiva, C Lagor, LS Lal, J Mueller, ... Blood 140 (Supplement 1), 13269-13270, 2022 | 1 | 2022 |
| Enhancing diversity in oncology clinical trials: findings of a case study in improving black patient representation in a multiple myeloma trial S Bhandari, C Lagor, J Mueller, W Whyte, S Heilbroner Blood 138, 3008, 2021 | 1 | 2021 |
| MP54-05 GEOGRAPHIC VARIATION IN UTILIZATION OF DOUBLET THERAPY FOR METASTATIC PROSTATE CANCER S Washington III, J Cowan, S Zhao, J Rider, N Taylor, W Whyte, P Carroll, ... The Journal of Urology 209 (Supplement 4), e755, 2023 | | 2023 |
| Geographic variation in utilization of doublet therapy for metastatic prostate cancer. SL Washington, JE Cowan, S Zhao, J Rider, N Taylor, W Whyte, P Carroll, ... Journal of Clinical Oncology 41 (6_suppl), 41-41, 2023 | | 2023 |
| Disparities in timely treatment among lung cancer patients. J Chhabra, H Ray, S Derkach, D Thompson, W Whyte Journal of Clinical Oncology 40 (16_suppl), e18515-e18515, 2022 | | 2022 |
| Evaluating the impact of performance status criteria on minority eligibility for oncology clinical trials. S Bhandari, J Mann, J Chawla, P Jain, M Knight, C Lagor, J Mueller, ... Journal of Clinical Oncology 40 (16_suppl), e18701-e18701, 2022 | | 2022 |
| Impact of trial site selection on minority patient recruitment in prostate cancer trials. C Lagor, S Bhandari, J Chawla, M Knight, J Mann, J Mueller, P Raska, ... Journal of Clinical Oncology 40 (16_suppl), 1558-1558, 2022 | | 2022 |
| Assessment of differences in demographic characteristics and clinical diagnoses among black and white oncology patients with COVID. S Bhandari, J Mueller, W Whyte, SP Heilbroner Journal of Clinical Oncology 39 (15_suppl), e18711-e18711, 2021 | | 2021 |
